Literature DB >> 28460395

Polymyalgia Rheumatica.

Eric L Matteson1, Christian Dejaco1.   

Abstract

This issue provides a clinical overview of polymyalgia rheumatica, focusing on risk factors, diagnosis, treatment, and practice improvement. The content of In the Clinic is drawn from the clinical information and education resources of the American College of Physicians (ACP), including MKSAP (Medical Knowledge and Self-Assessment Program). Annals of Internal Medicine editors develop In the Clinic in collaboration with the ACP's Medical Education and Publishing divisions and with the assistance of additional science writers and physician writers.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28460395     DOI: 10.7326/AITC201705020

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  17 in total

1.  A paraneoplastic syndrome exacerbated by checkpoint inhibition therapy.

Authors:  Heather Villarreal; Kathryn H Dao
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-10-12

Review 2.  [S3 guidelines on treatment of polymyalgia rheumatica : Evidence-based guidelines of the German Society of Rheumatology (DGRh), the Austrian Society of Rheumatology and Rehabilitation (ÖGR) and the Swiss Society of Rheumatology (SGT) and participating medical scientific specialist societies and other organizations].

Authors:  F Buttgereit; T Brabant; H Dinges; I Hiemer; M Kaplani; U Kiltz; D Kyburz; A Reißhauer; M Schneider; C Weseloh; C Dejaco
Journal:  Z Rheumatol       Date:  2018-06       Impact factor: 1.372

3.  Maximizing patient benefit through a reversed pathway from specialist to generalist: the case of chronic pain.

Authors:  Ioannis Karageorgiou; Stamatios Kokkinakis; Neofytos Maliotis; Christos Lionis; Emmanouil K Symvoulakis
Journal:  Med Pharm Rep       Date:  2021-10-30

Review 4.  Polymyalgia Rheumatica.

Authors:  Miriam Giovanna Colombo; Anna-Jasmin Wetzel; Hannah Haumann; Simon Dally; Gudula Kirtschig; Stefanie Joos
Journal:  Dtsch Arztebl Int       Date:  2022-06-17       Impact factor: 8.251

5.  Patient-Reported Outcomes Following Inpatient Multimodal Treatment Approach in Chronic Pain-Related Rheumatic Diseases.

Authors:  Tobias Romeyke; Elisabeth Noehammer; Harald Stummer
Journal:  Glob Adv Health Med       Date:  2020-08-20

6.  Paraneoplastic Syndrome Presenting with Polymyalgia Rheumatica-like Accumulations on 18F-fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography.

Authors:  Ayaka Umetsu; Toshimasa Shimizu; Naoki Iwamoto; Keiichi Hashiguchi; Mizuna Eguchi; Momoko Okamoto; Yushiro Endo; Sosuke Tsuji; Ayuko Takatani; Takashi Igawa; Remi Sumiyoshi; Tomohiro Koga; Shin-Ya Kawashiri; Kunihiro Ichinose; Mami Tamai; Hideki Nakamura; Tomoki Origuchi; Atsushi Kawakami
Journal:  Intern Med       Date:  2018-11-19       Impact factor: 1.271

7.  Incidence and Prevalence of Polymyalgia Rheumatica (PMR): The Importance of the Epidemiological Context. The Italian Case.

Authors:  Ciro Manzo
Journal:  Med Sci (Basel)       Date:  2019-08-30

8.  Thrombocytosis as a prognostic factor in polymyalgia rheumatica: characteristics determined from cluster analysis.

Authors:  Keigo Hayashi; Keiji Ohashi; Haruki Watanabe; Ken-Ei Sada; Kenta Shidahara; Yosuke Asano; Sumie Hiramatsu Asano; Yuriko Yamamura; Yoshia Miyawaki; Michiko Morishita; Yoshinori Matsumoto; Tomoko Kawabata; Jun Wada
Journal:  Ther Adv Musculoskelet Dis       Date:  2019-07-18       Impact factor: 5.346

9.  Comparison of Shoulder Ultrasonographic Assessments between Polymyalgia Rheumatica and Frozen Shoulder in Patients with Bilateral Shoulder Pain: A Comparative Retrospective Study.

Authors:  Eun-Woo Park; Jang-Hyuk Cho; Chul-Hyun Cho; Duk-Hyun Sung; Du-Hwan Kim
Journal:  J Pers Med       Date:  2021-05-03

10.  Polymyalgia Rheumatica (PMR) with Normal Values of Both Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) Concentration at the Time of Diagnosis in a Centenarian Man: A Case Report.

Authors:  Ciro Manzo
Journal:  Diseases       Date:  2018-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.